HTL Biotechnology is an international, fast-growing biotech and industrial actor leading the development and production of innovative pharmaceutical grade biopolymers used by top-tier companies from the pharmaceutical and medical devices sectors to transform the lives of millions of patients around the world.

HTL has been the world pioneer in industrializing the bioproduction of hyaluronic acid. For about 30 years, HTL has developed and refined a state-of-the-art biopolymers platform which provides customized, pharmaceutical grade biopolymers solutions to leading manufacturers of aesthetic medicine products worldwide, enabling them to take dermal filling and skin rejuvenation to the next level.
Today, HTL is at the forefront of innovation in the biopolymers sector both by creating new types of biopolymers and by exploring new possibilities of functionalization to be able to answer the medical needs of tomorrow.